Atherosclerosis Drugs Market to Reach $27.7 Billion, Globally, by 2032 at 3.0% CAGR: Allied Market Research

The global atherosclerosis drugs market is driven by factors such assurge in obesity in populace, increase in government initiatives to promote healthy lifestyle and development of new treatments for atherosclerosis PORTLAND, Ore., May 23, 2023 /PRNewswire/ — Allied Market Research…

Click here to view original post